Status:
COMPLETED
Oral Zinc Supplement as Adjunctive Therapy for Erosive Oral Lichen Planus
Lead Sponsor:
Hams Hamed Abdelrahman
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
Lichen Planus (LP) is a chronic mucocutaneous inflammatory disease and considered as T-cell mediated autoimmune disorder. Zinc is a potent antioxidant micronutrient that contributes to the proper fun...
Eligibility Criteria
Inclusion
- All patients involved in this clinical trial will have symptomatic OLP
Exclusion
- Smokers or tobacco users will be excluded from this clinical trial.
- Pregnant and lactating females.
- Any patient that has history of cancer, kidney, liver or other autoimmune disease will be excluded from this study.
- Patients showing dysplastic changes in their confirmatory biopsy specimen will be also excluded.
- Any patients presenting with extra oral lichen planus lesions will be excluded.
- Suspicious lesions of both lichenoid contact reaction and lichenoid drug reaction lesions will be excluded.
- Vitamin administration intake within the last 3 months
Key Trial Info
Start Date :
January 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06042010
Start Date
January 5 2023
End Date
February 14 2023
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Dentistry
Alexandria, Egypt